Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCX282-B in Celiac Disease
NCT00540657Phase 2Completed
- Sponsor
- Amgen
- Start
- Oct 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vercirnon in celiac disease, sponsored by Amgen. Started Oct 2007; status: completed.
02
Drugs
vercirnon
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT00540657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540657.